Delivery Order SPE2DB22D2206-SPE2DB25FEK97

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INFUVITE ADULT VIAL 10ML, a medical product, with a ceiling value of $6,413.18 and a period of performance through April 30, 2025. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of INFUVITE ADULT BULK VIAL 100ML medical products. The contract has a ceiling value of $19,288.02 and a period of performance through October 22, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,445.33, is for the delivery of INFUVITE ADULT BULK VIAL 100ML medical supplies. It is a firm fixed-price delivery order contract with a completion date of March 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a $10,191.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has an ultimate completion date of May 27, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,868.49, is for the delivery of Infuvite Adult Bulk Vial 100ML medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a critical medical product, to support federal healthcare programs. The contract has a ceiling value of $4,101.77 and is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,999.46 firm fixed-price delivery order is for the supply of 4568250414 - INFUVITE ADULT VIAL 10ML, with a performance period through May 15, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,616.01, is for the delivery of Infuvite Pediatric Vial 5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 8, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of INFUVITE ADULT VIAL 10ML medical supplies. The contract has a ceiling value of $1,044.53 and a completion date of June 23, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. The company holds a...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has a firm fixed price of $3,084.98 and a completion date of July 2, 2025. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEK97
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of INFUVITE ADULT BULK VIAL 100ML medical supplies. The contract has a ceiling value of $18,650.59 and runs through November 27, 2024. It is a Firm Fixed Price contract, with no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/25/25, 10:07 AM